Liver function tests in patients with acute heart failure

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue 10, 2012, Pages 471-479

  Biegus, Jan ^a   Zymlinśki, Robert ^a   Sokolski, Mateusz ^a,b   Nawrocka, Sylwia ^a   Siwołowski, Paweł ^a   Szachniewicz, Joanna ^a   Jankowska, Ewa A ^a,b   Banasiak, Waldemar ^a   Ponikowski, Piotr ^a,b  

^a 4TH MILITARY HOSPITAL   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Acute heart failure; Liver dysfunction; Liver function tests; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY HEMODYNAMICS; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART OUTPUT; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LIVER FUNCTION TEST; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PROGNOSIS; PULMONARY ARTERY OCCLUSION PRESSURE; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84868633690     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1413     Document Type: Article

References (17)

1. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009; 53: 557-573.
2. Ronco C, Haapio M, House AH, et al. Cardiorenal syndrome. J Am Coll Cardiol. 2008; 52: 1527-1539.
3. Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009; 11: 170-177.
4. Felder L, Mund A, Parker JG. Liver function tests in chronic congestive heart failure. Circulation. 1950; 2: 286-297.
5. Yu SB, Cui HY, Qin M, et al. [The prevalence and prognostic value of liver function abnormalities in patients in patients with chronic systolic heart failure]. Zhonghua Yi Xue Za Zhi. 2011; 18;91: 2673-2637. Chinese.
6. Szyguła-Jurkiewicz B, Wojnicz R, Lekston, et al. [Effect of elevated bilirubin levels on the long-term outcome in patients with chronic heart failure due to hypertension]. Pol Arch Med Wewn. 2007; 117: 227-233. Polish.
7. Poelzl G, Ess M, Mussner-Seeber Ch, et al. Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance. Eur J Clin Invest. 2012; 42: 153-163.
8. Poelzl G, Eberl Ch, Achrainer H, et al. Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure. Circ Heart Fail. 2009; 2: 294-302.
9. van Deursen VM, Damman K, Hillege HL, et al. Abnormal liver function in relation to hemodynamic profile in heart failure patients. J Cardiac Fail. 2010; 16: 84-90.
10. Ambrosy AP, Vaduganathan M, Huffman MD, et al. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail. 2012; 14: 302-311.
11. Dickstein K, Cohen-Solal A, Filippatos G, et al.; ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2008; 29: 2388-2442.
12. Shinagawa H, Inomata T, Koitabashi T, et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J. 2008; 72: 364-369. (Pubitemid 351600627)
13. Shinagawa H, Inomata T, Koitabashi T, et al. Increased serum bilirubin levels coincident with heart failure decompensation indicate the need for intravenous inotropic agents. Int Heart J. 2007; 48: 195-204. (Pubitemid 46603427)
14. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223-225. (Pubitemid 36135214)
15. Kaldara-Papatheodorou EE, Terrovitis JV, Nanas JN. Anemia in heart failure. Pol Arch Med Wewn. 2010; 120: 354-360.
16. Batin P, Wickens M, McEntegart D, et al. The importance of abnormalities of LFTs in predicting mortality in chronic heart failure. Eur Heart J. 1995; 16: 1613-1618. (Pubitemid 26037793)
17. Kubo SH, Walter BA, John DH. Liver function abnormalities in chronic heart failure influence of systemic hemodynamics. Arch Intern Med. 1987; 147: 1227-1230. (Pubitemid 17102148)